Article Details

HUTCHMED announces savolitinib approved in China for patients with lung cancer with MET exon ...

Retrieved on: 2021-06-22 17:15:00

Tags for this article:

Click the tags to see associated articles and topics

HUTCHMED announces savolitinib approved in China for patients with lung cancer with MET exon .... View article details on hiswai:

Excerpt

AstraZeneca's comprehensive portfolio includes leading lung cancer medicines and the next wave of innovations including TAGRISSO® (osimertinib) ...

Article found on: www.globenewswire.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up